博苑股份跌2.03%,成交额1673.74万元,主力资金净流入42.82万元

Group 1 - The core viewpoint of the news is that Baoyuan Co., Ltd. has experienced a significant stock price increase of 84.11% this year, despite a recent decline in the stock price over the past five trading days by 6.05% and 20 days by 9.01% [1] - As of December 30, Baoyuan's stock price is reported at 71.32 yuan per share, with a market capitalization of 9.531 billion yuan [1] - The company has been active in the stock market, appearing on the "Dragon and Tiger List" six times this year, with the most recent appearance on October 17, where it recorded a net buy of -20.2738 million yuan [1] Group 2 - Baoyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008. It specializes in the research, production, and sales of fine chemicals, including organic and inorganic iodides, precious metal catalysts, and luminescent materials [2] - The company's main business revenue composition includes iodides at 74.56%, specialty functional chemicals at 12.79%, trading business at 9.94%, and others at 2.72% [2] - As of December 19, the number of shareholders in Baoyuan is 8,851, a decrease of 2.88% from the previous period, with an average of 5,992 circulating shares per person, an increase of 63.45% [2] Group 3 - Baoyuan has distributed a total of 88.408 million yuan in dividends since its A-share listing [3] - As of September 30, 2025, the top ten circulating shareholders include several new institutional investors, with notable holdings such as 1.3456 million shares by Zhonghang New Start Flexible Allocation Mixed A [3]

Shandong Boyuan Pharmaceutical &Chemical Co.,Ltd-博苑股份跌2.03%,成交额1673.74万元,主力资金净流入42.82万元 - Reportify